No Data
No Data
Express News | Hoth Therapeutics Partners With Ontargetx R&D to Advance Research for Cancer Fighting Ht-Kit Cancer Therapeutic
Express News | Corrected-Hoth Therapeutics Shares Down 5% at $1.10 in Extended Trade Following Filing for Stock Offering (Deletes Erroneous Reference to Share Gain)
Express News | Hoth Therapeutics: Files for Common Stock Offering of up to $5 Mln - SEC Filing
Express News | Hoth Therapeutics Regains Compliance With Nasdaq Listing Requirements
H.C. Wainwright Maintains Hoth Therapeutics(HOTH.US) With Buy Rating, Maintains Target Price $4
HC Wainwright & Co. Reiterates Buy on Hoth Therapeutics, Maintains $4 Price Target